A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 100.96
GOOG 596.08
MSFT 47.52
BAC 16.95
FB 77.91

Recently Added

BABA 93.89
DCOM 14.93
CPLP 10.05
MBLY 47.85
ARO 3.71

Gaining Speed

MBLY 47.85
CPLP 10.05
BABA 93.89
DCOM 14.93
SSYS 126.06

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!